Molecular determinants for a cardiovascular collapse in anthrax
- PMID: 24389148
- PMCID: PMC4294697
- DOI: 10.2741/e697
Molecular determinants for a cardiovascular collapse in anthrax
Abstract
Bacillus anthracis releases two bipartite proteins, lethal toxin and edema factor, that contribute significantly to the progression of anthrax-associated shock. As blocking the anthrax toxins prevents disease, the toxins are considered the main virulence factors of the bacterium. The anthrax bacterium and the anthrax toxins trigger multi-organ failure associated with enhanced vascular permeability, hemorrhage and cardiac dysfunction in animal challenge models. A recent study using mice that either lacked the anthrax toxin receptor in specific cells and corresponding mice expressing the receptor in specific cell types demonstrated that cardiovascular cells are critical for disease mediated by anthrax lethal toxin. These studies are consistent with involvement of the cardiovascular system, and with an increase of cardiac failure markers observed in human anthrax and in animal models using B. anthracis and anthrax toxins. This review discusses the current state of knowledge regarding the pathophysiology of anthrax and tries to provide a mechanistic model and molecular determinants for the circulatory shock in anthrax.
Similar articles
-
The Potential Pathogenic Contributions of Endothelial Barrier and Arterial Contractile Dysfunction to Shock Due to B. anthracis Lethal and Edema Toxins.Toxins (Basel). 2017 Dec 6;9(12):394. doi: 10.3390/toxins9120394. Toxins (Basel). 2017. PMID: 29210983 Free PMC article. Review.
-
Anthrax-associated shock.Front Biosci. 2008 May 1;13:4009-14. doi: 10.2741/2988. Front Biosci. 2008. PMID: 18508494 Review.
-
New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.Microbes Infect. 2012 Feb;14(2):97-118. doi: 10.1016/j.micinf.2011.08.016. Epub 2011 Sep 8. Microbes Infect. 2012. PMID: 21930233 Free PMC article. Review.
-
Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.Microb Pathog. 2008 Jun;44(6):467-72. doi: 10.1016/j.micpath.2007.12.001. Epub 2007 Dec 23. Microb Pathog. 2008. PMID: 18222626
-
The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock.Toxins (Basel). 2011 Sep;3(9):1185-202. doi: 10.3390/toxins3091185. Epub 2011 Sep 20. Toxins (Basel). 2011. PMID: 22069762 Free PMC article. Review.
Cited by
-
A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection.Toxins (Basel). 2017 Mar 10;9(3):99. doi: 10.3390/toxins9030099. Toxins (Basel). 2017. PMID: 28287432 Free PMC article.
-
Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies.Toxins (Basel). 2015 Dec 12;7(12):5417-34. doi: 10.3390/toxins7124891. Toxins (Basel). 2015. PMID: 26703730 Free PMC article. Review.
-
A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines.PLoS One. 2016 Mar 23;11(3):e0148713. doi: 10.1371/journal.pone.0148713. eCollection 2016. PLoS One. 2016. PMID: 27007118 Free PMC article.
-
Multiple stages of evolutionary change in anthrax toxin receptor expression in humans.Nat Commun. 2021 Nov 15;12(1):6590. doi: 10.1038/s41467-021-26854-z. Nat Commun. 2021. PMID: 34782625 Free PMC article.
-
A proteolytic cascade controls lysosome rupture and necrotic cell death mediated by lysosome-destabilizing adjuvants.PLoS One. 2014 Jun 3;9(6):e95032. doi: 10.1371/journal.pone.0095032. eCollection 2014. PLoS One. 2014. PMID: 24893007 Free PMC article.
References
-
- Cui X, Moayeri M, Li Y, Li X, Haley M, Fitz Y, Correa-Araujo R, Banks SM, Leppla SH, Eichacker PQ. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am.J.Physiol Regul.Integr.Comp Physiol. 2004;286(4):R699–R709. - PubMed
-
- Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod.Pathol. 2001;14(5):482–495. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI033142/AI/NIAID NIH HHS/United States
- R01 AI033774/AI/NIAID NIH HHS/United States
- A1033774/PHS HHS
- R56 AI092497/AI/NIAID NIH HHS/United States
- R01 HL059842/HL/NHLBI NIH HHS/United States
- AI033142/AI/NIAID NIH HHS/United States
- 5U54AI05715807/AI/NIAID NIH HHS/United States
- R01 AI052733/AI/NIAID NIH HHS/United States
- U54 AI057158/AI/NIAID NIH HHS/United States
- HL059842-3/HL/NHLBI NIH HHS/United States
- 1R56AI092497-01A1/AI/NIAID NIH HHS/United States
- A1052733/PHS HHS
- R37 AI033142/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials